Phio Pharmaceuticals Corp. (PHIO)
1.125
-0.18
(-14.12%)
USD |
NASDAQ |
Dec 08, 16:00
1.15
+0.02
(+2.22%)
After-Hours: 20:00
Phio Pharmaceuticals EPS Diluted (Quarterly): -0.4374 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tharimmune, Inc. | -0.3367 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.392M |
| Total Expenses (Quarterly) | 2.392M |
| Enterprise Value | 3.396M |
| Earnings Yield | -198.9% |
| Normalized Earnings Yield | -198.91 |